MedTrace Logo

Metformin and Lifestyle Intervention in Women With Polycystic Ovary Syndrome

NCT00679679 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2008-05-19

No results posted yet for this study

Summary

Polycystic ovary syndrome is a frequent cause of abnormal menses and infertility. It has also been related to cardiovascular disease.

The objective of this trial is to evaluate the clinical and metabolic efficacy of metformin plus life style modifications in women with polycystic ovary syndrome compared with life style modifications and placebo

Conditions

  • Polycystic Ovary Syndrome

Interventions

DRUG

Metformin

Metformin 750 mg BID for 4 months

DRUG

Placebo

Diet counseling and exercise

Sponsors & Collaborators

  • Hospital Privado de Cordoba, Argentina

    lead OTHER

Principal Investigators

  • Carolina Fux Otta, MD

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-01-31
Primary Completion
2005-09-30
Completion
2005-12-31

Countries

  • Argentina

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00679679 on ClinicalTrials.gov